阿米卡星联合用药对中度敏感于第三代头孢菌素的肠杆菌科细菌的抗菌活性。
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
作者信息
Jones R N, Packer R R
出版信息
Antimicrob Agents Chemother. 1982 Dec;22(6):985-9. doi: 10.1128/AAC.22.6.985.
Abstract
Enterobacteriaceae strains having elevated minimal inhibitory concentrations (greater than or equal to 2.0 to less than or equal to 32 micrograms/ml) of cefoperazone, cefotaxime, ceftazidime, and moxalactam were synergistically inhibited by amikacin combinations (54.1 to 69.6% occurrence). Indifference was rare (8.1% for moxalactam), and true antagonistic interactions were not observed. Strains resistant or susceptible to these new cephalosporins were also synergistically inhibited by the addition of amikacin, reducing resistant cephalosporin minimal inhibitory concentrations to clinically achievable levels.
摘要
对头孢哌酮、头孢噻肟、头孢他啶和拉氧头孢的最低抑菌浓度升高（大于或等于2.0至小于或等于32微克/毫升）的肠杆菌科菌株，被阿米卡星联合用药协同抑制（发生率为54.1%至69.6%）。无协同作用的情况很少见（拉氧头孢为8.1%），且未观察到真正的拮抗相互作用。对这些新型头孢菌素耐药或敏感的菌株，加入阿米卡星后也被协同抑制，将耐药头孢菌素的最低抑菌浓度降低至临床可达到的水平。
相似文献
1
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
Antimicrob Agents Chemother. 1982 Dec;22(6):985-9. doi: 10.1128/AAC.22.6.985.
2
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0.
3
Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
Antimicrob Agents Chemother. 1984 Jun;25(6):725-8. doi: 10.1128/AAC.25.6.725.
4
[In vitro study of combinations between third-generation cephalosporins and aminoglycosides on Enterobacteriaceae].
Pathol Biol (Paris). 1983 Jun;31(6):483-7.
5
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Bol Asoc Med P R. 1985 Jun;77(6):242-4.
6
Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
Antimicrob Agents Chemother. 1984 Sep;26(3):378-81. doi: 10.1128/AAC.26.3.378.
7
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Aug;257(3):383-7.
8
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Diagn Microbiol Infect Dis. 1983 Dec;1(4):287-93. doi: 10.1016/0732-8893(83)90004-4.
9
In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria.
Antimicrob Agents Chemother. 1991 Dec;35(12):2652-4. doi: 10.1128/AAC.35.12.2652.
10
Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Drugs Exp Clin Res. 1986;12(4):325-7.
引用本文的文献
1
Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.
Antimicrob Agents Chemother. 1984 Sep;26(3):378-81. doi: 10.1128/AAC.26.3.378.
2
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1984 Apr;25(4):534-6. doi: 10.1128/AAC.25.4.534.
3
Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1983 Oct;26(4):279-333. doi: 10.2165/00003495-198326040-00001.
4
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Eur J Clin Microbiol. 1983 Oct;2(5):489-95. doi: 10.1007/BF02013914.
5
High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.
Eur J Clin Pharmacol. 1985;29(2):225-9. doi: 10.1007/BF00547427.
6
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
7
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
Antimicrob Agents Chemother. 1987 May;31(5):818-20. doi: 10.1128/AAC.31.5.818.
8
In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
J Clin Microbiol. 1987 Sep;25(9):1725-9. doi: 10.1128/jcm.25.9.1725-1729.1987.
9
In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1986 Jul;30(1):25-30. doi: 10.1128/AAC.30.1.25.
10
Antibiotic combinations: should they be tested?
Clin Microbiol Rev. 1988 Apr;1(2):139-56. doi: 10.1128/CMR.1.2.139.
本文引用的文献
1
Method of reliable determination of minimal lethal antibiotic concentrations.
Antimicrob Agents Chemother. 1980 Nov;18(5):699-708. doi: 10.1128/AAC.18.5.699.
2
Transferable multiple antibiotic resistance in Haemophilus influenzae.
J Antimicrob Chemother. 1981 Sep;8(3):187-92. doi: 10.1093/jac/8.3.187.
3
Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.
4
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
Antimicrob Agents Chemother. 1981 Aug;20(2):239-43. doi: 10.1128/AAC.20.2.239.
5
Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
Antimicrob Agents Chemother. 1980 Apr;17(4):750-6. doi: 10.1128/AAC.17.4.750.
6
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin.
Antimicrob Agents Chemother. 1980 Apr;17(4):743-9. doi: 10.1128/AAC.17.4.743.
7
Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Rev Infect Dis. 1982 Sep-Oct;4 Suppl:S366-73. doi: 10.1093/clinids/4.supplement_2.s366.
8
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1981 Feb;19(2):332-4. doi: 10.1128/AAC.19.2.332.
9
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
J Antimicrob Chemother. 1981 Mar;7(3):287-92. doi: 10.1093/jac/7.3.287.
10
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
Antimicrob Agents Chemother. 1980 Jul;18(1):88-93. doi: 10.1128/AAC.18.1.88.
Zotero 插件